retatrutide peptide microdose โ ๏ธ Stop microdosing Retatrutide, it's not how the science works. If you're only taking tiny daily doses of this powerful metabolic peptide, you're spending luxury money for budget results. Here's why ๐ Retatrutide Triple Agonist (GLP-1/GIP/GCG) |
Description
J.MorrisK

Use a travel cooler: There are many small, insulated carrying cases designed specifically for insulin or GLP-1 pens

The mechanism of action involves several physiological effects: GLP-1 receptor agonists stimulate insulin secretion in a glucose-dependent manner, suppress glucagon release, slow gastric emptying, and reduce appetite through central nervous system pathways

TG and TC were determined on a Cobas 6000 autoanalyzer (Roche, Basel, Switzerland), according to the manufacturers instructions

Key results at 80 weeks: Participants on the 4 mg dose lost an average of 47.2 lbs (19.0%) Participants on the 12 mg dose lost an average of 70.3 lbs (28.3%) 45.3% of participants on the 12 mg dose achieved at least 30% weight loss a level historically associated with bariatric surgery outcomes The 4 mg dose showed a lower rate of discontinuation due to adverse events than even placebo In a study extension to 104 weeks, participants with a starting BMI of 35 or higher who received 12 mg lost up to an average of 85.0 lbs (30.3%)

Building a Combined Plan With Your Care Team Because GLP-1-related skin changes sit at the intersection of weight management, endocrinology, and aesthetic medicine, I think the best outcomes happen when these different parts of a patient's care are actually communicating rather than operating in silos
